Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (15)

2020

  1. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2003

  1. Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

    AIDS, Vol. 17, Núm. 7, pp. 1023-1028

  2. Primary resistance mutations to fusion inhibitors and polymorphisms in gp41 sequences of HIV-1 non-B subtypes and recombinants

    AIDS, Vol. 17, Núm. 7, pp. 1083-1086

2001

  1. Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

    AIDS, Vol. 15, Núm. 13, pp. 1701-1706

  2. Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia)

    Journal of Human Virology, Vol. 4, Núm. 1, pp. 35-38

1997

  1. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 35, Núm. 3, pp. 225-230

1996

  1. TRATAMIENTO DE LA HEPATITIS CRONICA C CON INTERFERON EN PACIENTES INFECTADOS POR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA

    Medicina Clinica, Vol. 106, Núm. 13, pp. 486-490

1995

  1. Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 31, Núm. 1, pp. 9-13

  2. High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain

    Journal of Hepatology, Vol. 22, Núm. 5, pp. 598-599

1994

  1. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C [1]

    AIDS

1992

  1. Idiopathic CD4+ T-lymphocytopenia

    The Lancet

  2. Kaposi's sarcoma and disseminated tuberculosis in HIV-negative individual

    The Lancet